Emergent BioSolutions (EBS) Tops Q2 EPS by 18c
Tweet
Share
E-mailGet Alerts EBS Hot Sheet
Price: $6.00 -3.38%
EPS Growth %: -138.7%
Financial Fact:
Selling, general and administrative: 40.69M
Today's EPS Names:
CULP, KFY, NNOX, More
EPS Growth %: -138.7%
Financial Fact:
Selling, general and administrative: 40.69M
Today's EPS Names:
CULP, KFY, NNOX, More
Join SI Premium – FREE
Emergent BioSolutions (NYSE: EBS) reported Q2 EPS of $0.36, $0.18 better than the analyst estimate of $0.18. Revenue for the quarter came in at $126.1 million versus the consensus estimate of $114.25 million.
Emergent BioSolutions reaffirmed FY2015 guidance.
For earnings history and earnings-related data on Emergent BioSolutions (EBS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Casey's General Stores (CASY) Tops Q1 EPS by 69c
- ServiceTitan, Inc. (TTAN) Misses Q2 EPS by 1c, Offers Guidance
- Morgan Stanley Downgrades Vend Marketplaces (VEND:NO) to Equalweight
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
